Immucor Acquires Gamma Biologicals
TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
Sapheon Acquired by Covidien plc
TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration
UltiMed has been acquired by Levine Leichtman Capital Partners
TM Capital served as exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in its sale to an investment vehicle sub-managed by Levine Leichtman Capital Partners
NanoGram Devices Acquired by Greatbatch
TM Capital advised NanoGram Devices Corporation in its sale to Greatbatch, Inc. (NYSE: GB) for $45 million in cash
VIP Petcare Acquired by PetIQ
TM Capital served as exclusive financial advisor to VIP Petcare in its sale to PetIQ, Inc. (NasdaqGS:PETQ) for approximately $230 million in cash, stock and notes
CorVista Raises Equity Capital
TM Capital advised CorVista Health, Inc. in raising $65 million of Series C equity capital to advance its artificial intelligence-based cardiovascular diagnostic technology
